GOOGL   1,512.30 (+0.84%)
AMZN   3,041.62 (-0.50%)
NVDA   400.08 (+1.65%)
TSLA   1,390.31 (+1.37%)
AMD   53.33 (-0.13%)
T   30.35 (-0.46%)
DIS   113.48 (-0.82%)
BAC   23.08 (-2.45%)
NFLX   494.21 (+0.08%)
GOOGL   1,512.30 (+0.84%)
AMZN   3,041.62 (-0.50%)
NVDA   400.08 (+1.65%)
TSLA   1,390.31 (+1.37%)
AMD   53.33 (-0.13%)
T   30.35 (-0.46%)
DIS   113.48 (-0.82%)
BAC   23.08 (-2.45%)
NFLX   494.21 (+0.08%)
GOOGL   1,512.30 (+0.84%)
AMZN   3,041.62 (-0.50%)
NVDA   400.08 (+1.65%)
TSLA   1,390.31 (+1.37%)
AMD   53.33 (-0.13%)
T   30.35 (-0.46%)
DIS   113.48 (-0.82%)
BAC   23.08 (-2.45%)
NFLX   494.21 (+0.08%)
GOOGL   1,512.30 (+0.84%)
AMZN   3,041.62 (-0.50%)
NVDA   400.08 (+1.65%)
TSLA   1,390.31 (+1.37%)
AMD   53.33 (-0.13%)
T   30.35 (-0.46%)
DIS   113.48 (-0.82%)
BAC   23.08 (-2.45%)
NFLX   494.21 (+0.08%)
Log in

NASDAQ:DMACDiaMedica Therapeutics News Headlines

$6.89
-0.21 (-2.96 %)
(As of 07/7/2020 12:37 PM ET)
Add
Compare
Today's Range
$6.20
Now: $6.89
$6.89
50-Day Range
$4.46
MA: $5.52
$7.32
52-Week Range
$1.70
Now: $6.89
$8.80
Volume48 shs
Average Volume90,586 shs
Market Capitalization$97.42 million
P/E RatioN/A
Dividend YieldN/A
Beta2.86

Headlines

DiaMedica Therapeutics (NASDAQ DMAC) News Headlines

Source:
DateHeadline
DiaMedica Therapeutics Inc (NASDAQ:DMAC) Expected to Post Earnings of -$0.28 Per ShareDiaMedica Therapeutics Inc (NASDAQ:DMAC) Expected to Post Earnings of -$0.28 Per Share
www.americanbankingnews.com - July 4 at 1:16 PM
DiaMedica Therapeutics Inc (NASDAQ:DMAC) Sees Significant Drop in Short InterestDiaMedica Therapeutics Inc (NASDAQ:DMAC) Sees Significant Drop in Short Interest
www.americanbankingnews.com - June 18 at 10:38 PM
 Brokerages Expect DiaMedica Therapeutics Inc (NASDAQ:DMAC) to Announce -$0.28 EPS Brokerages Expect DiaMedica Therapeutics Inc (NASDAQ:DMAC) to Announce -$0.28 EPS
www.americanbankingnews.com - June 12 at 5:25 PM
DiaMedica Therapeutics to Present at the 17th Annual Craig-Hallum Institutional Investor Conference on May 27, 2020DiaMedica Therapeutics to Present at the 17th Annual Craig-Hallum Institutional Investor Conference on May 27, 2020
finance.yahoo.com - May 19 at 7:03 PM
DiaMedica Therapeutics Inc.s (DMAC) CEO Rick Pauls on Q1 2020 Results - Earnings Call TranscriptDiaMedica Therapeutics Inc.'s (DMAC) CEO Rick Pauls on Q1 2020 Results - Earnings Call Transcript
seekingalpha.com - May 14 at 5:33 PM
DiaMedica Therapeutics EPS beats by $0.09DiaMedica Therapeutics EPS beats by $0.09
seekingalpha.com - May 13 at 9:30 PM
DiaMedica Announces Positive Results in Top-Line Data from the Phase II ReMEDy Acute Ischemic Stroke Study and Provides a Business Update and First Quarter 2020 Financial ResultsDiaMedica Announces Positive Results in Top-Line Data from the Phase II ReMEDy Acute Ischemic Stroke Study and Provides a Business Update and First Quarter 2020 Financial Results
finance.yahoo.com - May 13 at 9:30 PM
DiaMedica Announces Positive Results in Top-Line Data From the Phase II ReMEDy Acute Ischemic Stroke StudyDiaMedica Announces Positive Results in Top-Line Data From the Phase II ReMEDy Acute Ischemic Stroke Study
finance.yahoo.com - May 13 at 9:30 PM
DiaMedica Therapeutics to Report First Quarter 2020 Financial Results and Provide a Business Update May 14, 2020DiaMedica Therapeutics to Report First Quarter 2020 Financial Results and Provide a Business Update May 14, 2020
finance.yahoo.com - May 7 at 7:21 PM
DiaMedica Therapeutics to Present Research at National Kidney Foundation 2020 Spring Clinical Meetings Live Virtual ConferenceDiaMedica Therapeutics to Present Research at National Kidney Foundation 2020 Spring Clinical Meetings Live Virtual Conference
finance.yahoo.com - March 26 at 1:25 PM
DiaMedica Therapeutics Inc. (DMAC) CEO Rick Pauls on Q4 2019 Results - Earnings Call TranscriptDiaMedica Therapeutics Inc. (DMAC) CEO Rick Pauls on Q4 2019 Results - Earnings Call Transcript
seekingalpha.com - March 24 at 1:46 PM
BRIEF-Diamedica Therapeutics Says Remedy Phase II Study Of Dm199 Completes EnrollmentBRIEF-Diamedica Therapeutics Says Remedy Phase II Study Of Dm199 Completes Enrollment
www.reuters.com - March 23 at 10:45 PM
DiaMedica Therapeutics EPS beats by $0.04DiaMedica Therapeutics EPS beats by $0.04
seekingalpha.com - March 23 at 5:44 PM
DiaMedica Therapeutics Announces 2019 Financial Results and Provides Business UpdateDiaMedica Therapeutics Announces 2019 Financial Results and Provides Business Update
finance.yahoo.com - March 23 at 5:44 PM
DiaMedica Therapeutics to Report Fourth Quarter...DiaMedica Therapeutics to Report Fourth Quarter...
www.benzinga.com - March 17 at 12:30 PM
DiaMedica Therapeutics to Report Fourth Quarter 2019 Financials and Provide a Business Update March 24, 2020DiaMedica Therapeutics to Report Fourth Quarter 2019 Financials and Provide a Business Update March 24, 2020
finance.yahoo.com - March 17 at 12:30 PM
DiaMedica Therapeutics to Participate at 32nd Annual ROTH Conference on March 15-17, 2020DiaMedica Therapeutics to Participate at 32nd Annual ROTH Conference on March 15-17, 2020
finance.yahoo.com - March 9 at 9:17 AM
DiaMedica Therapeutics Announces Closing of $8.5 Million Public Offering of Common SharesDiaMedica Therapeutics Announces Closing of $8.5 Million Public Offering of Common Shares
finance.yahoo.com - February 13 at 5:15 PM
DiaMedica prices equity offering; shares down 9% premarketDiaMedica prices equity offering; shares down 9% premarket
seekingalpha.com - February 11 at 12:30 PM
DiaMedica Announces Pricing of Public Offering of Common SharesDiaMedica Announces Pricing of Public Offering of Common Shares
finance.yahoo.com - February 11 at 7:30 AM
Hedge Funds Have Never Been More Bullish On DiaMedica Therapeutics Inc. (DMAC)Hedge Funds Have Never Been More Bullish On DiaMedica Therapeutics Inc. (DMAC)
finance.yahoo.com - December 23 at 5:28 PM
DiaMedica Therapeutics Announces First Patient Dosed in REDUX Phase II Clinical Trial of DM199 for the Treatment of Chronic Kidney DiseaseDiaMedica Therapeutics Announces First Patient Dosed in REDUX Phase II Clinical Trial of DM199 for the Treatment of Chronic Kidney Disease
finance.yahoo.com - December 17 at 5:53 PM
DiaMedica Therapeutics Inc. (DMAC) CEO Rick Pauls on Q3 2019 Results - Earnings Call TranscriptDiaMedica Therapeutics Inc. (DMAC) CEO Rick Pauls on Q3 2019 Results - Earnings Call Transcript
seekingalpha.com - November 14 at 5:54 PM
DiaMedica Therapeutics Announces Third Quarter 2019 Financial Results and Provides Business UpdateDiaMedica Therapeutics Announces Third Quarter 2019 Financial Results and Provides Business Update
finance.yahoo.com - November 13 at 7:50 PM
DiaMedica Therapeutics to Report Third Quarter 2019 Financials and Provide a Business Update November 14, 2019DiaMedica Therapeutics to Report Third Quarter 2019 Financials and Provide a Business Update November 14, 2019
finance.yahoo.com - November 6 at 8:47 PM
DiaMedica Therapeutics to Participate in 10th Annual Craig-Hallum Alpha Select ConferenceDiaMedica Therapeutics to Participate in 10th Annual Craig-Hallum Alpha Select Conference
finance.yahoo.com - November 5 at 5:23 PM
DiaMedica receives FDA clearance to initiate mid-stage DM199 trial for CKDDiaMedica receives FDA clearance to initiate mid-stage DM199 trial for CKD
seekingalpha.com - October 14 at 9:57 AM
DiaMedica Therapeutics Announces Clearance to Initiate Phase II Clinical Trial of DM199 for Chronic Kidney DiseaseDiaMedica Therapeutics Announces Clearance to Initiate Phase II Clinical Trial of DM199 for Chronic Kidney Disease
finance.yahoo.com - October 14 at 9:57 AM
DiaMedica Therapeutics (DMAC) Presents At 4th Annual Dougherty & Company Institutional Investor Conference - SlideshowDiaMedica Therapeutics (DMAC) Presents At 4th Annual Dougherty & Company Institutional Investor Conference - Slideshow
seekingalpha.com - September 11 at 3:58 PM
DiaMedica Therapeutics to Present at Lake Street’s 3rd Annual Best Ideas Growth (BIG3) Conference on September 12, 2019DiaMedica Therapeutics to Present at Lake Street’s 3rd Annual Best Ideas Growth (BIG3) Conference on September 12, 2019
finance.yahoo.com - September 6 at 4:23 PM
DiaMedica Therapeutics to Present at the 2019 Dougherty & Co. Institutional Investor ConferenceDiaMedica Therapeutics to Present at the 2019 Dougherty & Co. Institutional Investor Conference
finance.yahoo.com - September 3 at 6:01 PM
61 Biggest Movers From Yesterday61 Biggest Movers From Yesterday
www.msn.com - August 15 at 8:43 PM
DiaMedica Therapeutics Inc. (DMAC) CEO Rick Pauls on Q2 2019 Results - Earnings Call TranscriptDiaMedica Therapeutics Inc. (DMAC) CEO Rick Pauls on Q2 2019 Results - Earnings Call Transcript
seekingalpha.com - August 14 at 3:41 PM
DiaMedica Therapeutics EPS beats by $0.05DiaMedica Therapeutics EPS beats by $0.05
seekingalpha.com - August 13 at 8:45 PM
DiaMedica Therapeutics Announces Second Quarter 2019 Financial Results and Provides Business UpdateDiaMedica Therapeutics Announces Second Quarter 2019 Financial Results and Provides Business Update
finance.yahoo.com - August 13 at 8:45 PM
DiaMedica Therapeutics to Present at the 2019 Intellisight Investor Conference on August 14, 2019DiaMedica Therapeutics to Present at the 2019 Intellisight Investor Conference on August 14, 2019
finance.yahoo.com - August 12 at 12:51 PM
DiaMedica Therapeutics to Report Second Quarter 2019 Financials and Provide a Business Update August 13, 2019DiaMedica Therapeutics to Report Second Quarter 2019 Financials and Provide a Business Update August 13, 2019
finance.yahoo.com - August 8 at 8:45 PM
AUY, HL among premarket gainersAUY, HL among premarket gainers
seekingalpha.com - June 20 at 11:47 AM
DiaMedica Therapeutics Announces Interim Results from Phase 1b Trial of DM199 in Chronic Kidney Disease ParticipantsDiaMedica Therapeutics Announces Interim Results from Phase 1b Trial of DM199 in Chronic Kidney Disease Participants
finance.yahoo.com - June 19 at 8:40 PM
DiaMedica Therapeutics to Present at the 16th Annual Craig-Hallum Institutional Investor ConferenceDiaMedica Therapeutics to Present at the 16th Annual Craig-Hallum Institutional Investor Conference
www.nasdaq.com - May 22 at 10:42 AM
DiaMedica Therapeutics Announces Formation of Scientific Advisory Board for Kidney DiseaseDiaMedica Therapeutics Announces Formation of Scientific Advisory Board for Kidney Disease
finance.yahoo.com - May 21 at 3:37 PM
DiaMedica Therapeutics Inc. (DMAC) CEO Rick Pauls on Q1 2019 Results - Earnings Call TranscriptDiaMedica Therapeutics Inc. (DMAC) CEO Rick Pauls on Q1 2019 Results - Earnings Call Transcript
seekingalpha.com - May 14 at 3:42 PM
DiaMedica Therapeutics Announces First Quarter 2019 Financial Results and Provides Business UpdateDiaMedica Therapeutics Announces First Quarter 2019 Financial Results and Provides Business Update
finance.yahoo.com - May 14 at 7:16 AM
DiaMedica Therapeutics, Inc. to Host Earnings CallDiaMedica Therapeutics, Inc. to Host Earnings Call
finance.yahoo.com - May 14 at 7:16 AM
DiaMedica Therapeutics to Report First Quarter 2019 Financials and Provide an Update on DevelopmentDiaMedica Therapeutics to Report First Quarter 2019 Financials and Provide an Update on Development
www.nasdaq.com - May 6 at 9:40 AM
DiaMedica Therapeutics to Report First Quarter 2019 Financials and Provide an Update on Development Programs on May 14, 2019DiaMedica Therapeutics to Report First Quarter 2019 Financials and Provide an Update on Development Programs on May 14, 2019
finance.yahoo.com - May 6 at 9:40 AM
Diamedica Therapeutics Inc.Diamedica Therapeutics Inc.
www.barrons.com - March 23 at 8:56 AM
DiaMedica Therapeutics Inc. (DMAC) CEO Rick Pauls on Q4 2018 Results - Earnings Call TranscriptDiaMedica Therapeutics Inc. (DMAC) CEO Rick Pauls on Q4 2018 Results - Earnings Call Transcript
seekingalpha.com - March 20 at 3:28 PM
DiaMedica Therapeutics Announces 2018 Financial Results and Provides Corporate UpdateDiaMedica Therapeutics Announces 2018 Financial Results and Provides Corporate Update
finance.yahoo.com - March 20 at 8:41 AM
DiaMedica Therapeutics Announces Date for the Release of Full Year 2018 Results and Conference CallDiaMedica Therapeutics Announces Date for the Release of Full Year 2018 Results and Conference Call
finance.yahoo.com - March 18 at 3:34 PM
This page was last updated on 7/7/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.